Literature DB >> 22242615

Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.

Cristina Ripoll1, Paola Lastra, Diego Rincón, Vega Catalina, Rafael Bañares.   

Abstract

AIM: Identification of predictors in the natural history of cirrhosis is based on determinations at a fixed time point. However, changes of these predictors may offer more information. To evaluate the predictive value of Model for End Stage Liver Disease (MELD) and hepatic venous pressure gradient (HVPG) and their changes in cirrhosis.
METHODS: Patients with repeat HVPG measurements between January 2000 and December 2008 were considered for inclusion. Patients were followed until decompensation/death or July 2009. Multivariate Cox regression was used to analyze the predictive value of a single measurement of MELD and HVPG, and changes between measurements. Compensated and decompensated patients were analyzed separately.
RESULTS: One hundred and seventeen patients were included (51 compensated, 66 decompensated). Median time between measurements and follow-up was 13 (2-24) and 11 (6-38) months in compensated and 8 (1-16) and 10 (3-21) months in decompensated patients, respectively. Fifteen compensated patients developed decompensation while twelve decompensated patients died. On multivariate analysis, MELD (HR 1.12 (95% CI 1-1.24)) and HVPG (HR 1.16 (95% CI 1.04-1.29)) were independent predictors of decompensation in compensated, while MELD (HR 1.18 (95% CI 1.09-1.27)) was the only predictor of death in the decompensated.
CONCLUSION: Single and repeat measurements of MELD and HVPG are associated to outcomes in cirrhosis. Use of repeat measurements does not seem to add further information.

Entities:  

Mesh:

Year:  2012        PMID: 22242615     DOI: 10.3109/00365521.2011.645500

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Natural history of cirrhosis.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Curr Gastroenterol Rep       Date:  2013-02

2.  Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Arun J Sanyal; Veronica Miller
Journal:  Gastroenterology       Date:  2016-02-26       Impact factor: 22.682

3.  Risk factors for early rebleeding and mortality in acute variceal hemorrhage.

Authors:  Jing-Run Zhao; Guang-Chuan Wang; Jin-Hua Hu; Chun-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

4.  Role of magnetic resonance elastography in compensated and decompensated liver disease.

Authors:  Sumeet K Asrani; Jayant A Talwalkar; Patrick S Kamath; Vijay H Shah; Giovanna Saracino; Linda Jennings; John B Gross; Sudhakar Venkatesh; Richard L Ehman
Journal:  J Hepatol       Date:  2013-12-19       Impact factor: 25.083

5.  Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.

Authors:  Theresa Bucsics; Maria Schoder; Magdalena Diermayr; Maria Feldner-Busztin; Nicolas Goeschl; David Bauer; Philipp Schwabl; Mattias Mandorfer; Bernhard Angermayr; Manfred Cejna; Arnulf Ferlitsch; Wolfgang Sieghart; Michael Trauner; Markus Peck-Radosavljevic; Josef Karner; Franz Karnel; Thomas Reiberger
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

6.  Compensating effect of minor portal hypertension on the muscle mass loss-related poor prognosis in cirrhosis.

Authors:  Hitoshi Maruyama; Kazufumi Kobayashi; Soichiro Kiyono; Sadahisa Ogasawara; Eichiro Suzuki; Yoshihiko Ooka; Tetsuhiro Chiba; Tadashi Yamaguchi
Journal:  Int J Med Sci       Date:  2017-07-19       Impact factor: 3.738

7.  Biomarkers in liver disease: emerging methods and potential applications.

Authors:  Guruprasad P Aithal; Neil Guha; Jonathan Fallowfield; Laurent Castera; Andrew P Jackson
Journal:  Int J Hepatol       Date:  2012-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.